Engineered Cell Fermentation for Multi-Oligosaccharide Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing oligosaccharide mixtures are laborious, time-consuming, and difficult to scale up, often resulting in the synthesis of a single oligosaccharide due to challenges in stereospecificity and regioselectivity of glycosyltransferases, and the need for in situ regeneration of nucleotide-sugar donors.
Innovation Solution
A metabolically engineered cell expressing multiple glycosyltransferases and capable of synthesizing nucleotide-sugar donors is cultivated under specific conditions to produce a mixture of at least three different oligosaccharides, with methods for separating individual oligosaccharides from the mixture.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If chemical synthesis methods are used to produce oligosaccharides, then oligosaccharides can be produced, but the process becomes laborious, time-consuming, and difficult to scale-up
Solution Approach 1:
The patent replaces chemical synthesis methods with a biological system (metabolically engineered cells) to produce oligosaccharides. The cell's metabolic pathways and glycosyltransferase enzymes naturally catalyze the formation of oligosaccharide bonds, eliminating the need for complex chemical reagents, multiple synthesis steps, and stringent chemical reaction control conditions. This biological substitution dramatically simplifies the overall process while enabling scalable production.
Solution Approach 2:
The metabolically engineered cell possesses endogenous pathways for synthesizing nucleotide-sugar donors and glycosyltransferases, allowing it to self-supply the necessary components for oligosaccharide production. The cell autonomously maintains the pools of activated sugar donors and expresses the required enzymes, eliminating the need for external regeneration systems or continuous addition of costly chemical reagents.
2Ease of manufacture
If enzymatic approaches using glycosyltransferases are used, then advantages above chemical synthesis are offered, but stereospecificity and regioselectivity remain formidable challenges
Solution Approach 1:
The patent employs multiple different glycosyltransferases, each with its own specific substrate specificity, stereospecificity, and regioselectivity characteristics. By selecting and combining enzymes with complementary properties, the system achieves precise control over the stereochemistry and regiochemistry of each glycosidic bond formed. Each enzyme operates with its optimal specificity profile, collectively producing the desired complex oligosaccharide structure with high precision.
Solution Approach 2:
The patent creates a composite enzymatic system within the cell that combines multiple glycosyltransferases with different specificities. This composite enzyme system works synergistically to build complex oligosaccharide structures with precise stereochemical and regiochemical control that cannot be achieved with a single enzyme, effectively solving the selectivity challenges through enzymatic diversity.
3Productivity
If chemo-enzymatic approaches are used, then oligosaccharides can be synthesized, but in situ regeneration of nucleotide-sugar donors is required
Solution Approach 1:
The metabolically engineered cell contains complete endogenous pathways for synthesizing all required nucleotide-sugar donors (UDP-glucose, UDP-galactose, GDP-fucose, CMP-sialic acid, etc.). The cell's own metabolism generates these activated sugar precursors continuously, eliminating the need for external regeneration systems, costly exogenous additions, or complex chemo-enzymatic coupling reactions required in conventional approaches.
4Productivity
If cellular production of oligosaccharides is used, then production can occur, but tight control of spatiotemporal availability of nucleotide-sugar donors near glycosyltransferases is needed
Solution Approach 1:
The patent merges the synthesis pathways for nucleotide-sugar donors with the glycosyltransferase catalytic activities within the same cellular compartment and metabolic network. The enzymes responsible for generating activated sugar donors (such as sugar phosphates, sugar nucleotide pyrophosphorylases, and kinases) are co-localized with the glycosyltransferases in the cell's cytoplasm and membrane structures, ensuring immediate availability of substrates at the site of action without requiring complex external control mechanisms.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables efficient, cost-effective production of a diverse oligosaccharide mixture by a single cell, overcoming the limitations of traditional methods and allowing for continuous process scalability.
Implementation Method 1
Glycosyltransferases catalyze the transfer of a sugar moiety from an activated nucleotide-sugar donor onto saccharide or non-saccharide acceptors
Implementation Method 2
the cell is genetically modified for the production of the oligosaccharides... providing a cell that expresses at least two glycosyltransferases and is capable of synthesizing (a) nucleotide-sugar(s) that is/are donor(s) for the glycosyltransferases
Data Source
AI summary
This disclosure is in the technical field of synthetic biology and metabolic engineering. More particularly, this disclosure is in the technical field of cultivation or fermentation of metabolically engineered cells. This disclosure describes a cell metabolically engineered for production of a mixture of at least three different oligosaccharides. Furthermore, this disclosure provides a method for the production of a mixture of at least three different oligosaccharides by a cell as well as the purification of at least one of the oligosaccharides from the cultivation.